| 1ZUA | X:15-294 | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ AND TOLRESTAT |
| 1MRQ | A:18-301 | CRYSTAL STRUCTURE OF HUMAN 20ALPHA-HSD IN TERNARY COMPLEX WITH NADP AND 20ALPHA-HYDROXY-PROGESTERONE |
| 3NTY | A:18-301 | CRYSTAL STRUCTURE OF AKR1C1 IN COMPLEX WITH NADP AND 5-PHENYL,3-CHLOROSALICYLIC ACID |
| 1XJB | B:18-301; B:18-301 | CRYSTAL STRUCTURE OF HUMAN TYPE 3 3ALPHA-HYDROXYSTEROID DEHYDROGENASE IN COMPLEX WITH NADP(H), CITRATE AND ACETATE MOLECULES |
| 1RY0 | B:18-301; B:18-301 | STRUCTURE OF PROSTAGLANDIN F SYNTHASE WITH PROSTAGLANDIN D2 |
| 1RY8 | B:18-301; B:18-301 | PROSTAGLANDIN F SYNTHASE COMPLEXED WITH NADPH AND RUTIN |
| 1S1P | A:18-301 | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
| 1S1R | A:18-301 | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
| 1S2A | A:18-301 | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
| 1XF0 | A:18-301 | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) COMPLEXED WITH DELTA4-ANDROSTENE-3,17-DIONE AND NADP |
| 1ZQ5 | A:18-301 | CRYSTAL STRUCTURE OF HUMAN ANDROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEXED WITH A POTENT INHIBITOR EM1404 |
| 1PWL | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND MINALRESTAT |
| 1PWM | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND FIDARESTAT |
| 1T40 | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 AT PH 5 |
| 1T41 | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 |
| 1US0 | A:14-293 | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594 AT 0.66 ANGSTROM |
| 1X96 | A:14-293 | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE WITH CITRATES BOUND IN THE ACTIVE SITE |
| 1X97 | A:14-293 | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2R4S (STEREOISOMER OF FIDARESTAT, 2S4S) |
| 1X98 | A:14-293 | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2S4R (STEREOISOMER OF FIDARESTAT, 2S4S) |
| 1XGD | A:14-293 | APO R268A HUMAN ALDOSE REDUCTASE |
| 1Z3N | A:14-293 | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR LIDORESTAT AT 1.04 ANGSTROM |
| 1Z8A | A:14-293 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL SULFONYL-PYRIDAZINONE INHIBITOR |
| 2NVC | A:14-293 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL NAPHTHO[1,2-D]ISOTHIAZOLE ACETIC ACID DERIVATIVE (3) |
| 2NVD | A:14-293 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL NAPHTHO[1,2-D]ISOTHIAZOLE ACETIC ACID DERIVATIVE (2) |
| 2PD5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT V47I COMPLEXED WITH ZOPOLRESTAT |
| 2PD9 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT V47I COMPLEXED WITH FIDARESTAT. |
| 2PDB | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT F121P COMPLEXED WITH ZOPOLRESTAT. |
| 2PDC | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT F121P COMPLEXED WITH IDD393. |
| 2PDF | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT L300P COMPLEXED WITH ZOPOLRESTAT. |
| 2PDH | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT L300P COMPLEXED WITH URACIL-TYPE INHIBITOR AT 1.45 A. |
| 2PDI | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT L300A COMPLEXED WITH ZOPOLRESTAT AT 1.55 A. |
| 2PDN | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT S302R COMPLEXED WITH URACIL-TYPE INHIBITOR. |
| 2PDP | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT S302R COMPLEXED WITH IDD 393. |
| 2PDQ | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH URACIL-TYPE INHIBITOR. |
| 2PDU | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH IDD393. |
| 2PDW | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH FIDARESTAT. |
| 2PDX | A:14-293 | HUMAN ALDOSE REDUCTASE DOUBLE MUTANT S302R-C303D COMPLEXED WITH ZOPOLRESTAT. |
| 2PDY | A:14-293 | HUMAN ALDOSE REDUCTASE DOUBLE MUTANT S302R-C303D COMPLEXED WITH FIDARESTAT. |
| 2PEV | A:14-293 | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION EXCEEDS CONCENTRATION OF IDD594. |
| 2PF8 | A:14-293 | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION IS EQUAL TO CONCENTRATION OF IDD594. |
| 2PFH | A:14-293 | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION IS LESS THAN CONCENTRATION OF IDD594. |
| 2PZN | A:14-293 | THE CRYSTALLOGRAPHIC STRUCTURE OF ALDOSE REDUCTASE IDD393 COMPLEX CONFIRMS LEU300 AS A SPECIFICITY DETERMINANT |
| 2QXW | A:14-293 | PERDEUTERATED ALR2 IN COMPLEX WITH IDD594 |
| 2R24 | A:14-293 | HUMAN ALDOSE REDUCTASE STRUCTURE |
| 3LBO | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113C COMPLEXED WITH IDD594 |
| 3LD5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD594 |
| 3LEN | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH ZOPOLRESTAT |
| 3LEP | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113C IN COMPLEX WITH IDD388 |
| 3LQG | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD388 |
| 3LQL | A:15-294 | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD 594 |
| 3LZ3 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD388 |
| 3LZ5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD594 |
| 3M0I | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V IN COMPLEX WITH ZOPOLRESTAT |
| 3M4H | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD388 |
| 3M64 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD393 |
| 3MB9 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH ZOPOLRESTAT |
| 3MC5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V IN COMPLEX WITH IDD393 CRYSTALLIZED IN SPACEGROUP P1 |
| 3Q65 | B:14-293; B:14-293 | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ IN SPACE GROUP P212121 |
| 3Q67 | B:14-293; B:14-293 | HUMAN ALDOSE REDUCTASE C298S MUTANT IN COMPLEX WITH NADP+ IN SPACE GROUP P212121 |
| 1ZSX | A:37-332 | CRYSTAL STRUCTURE OF HUMAN POTASSIUM CHANNEL KV BETA-SUBUNIT (KCNAB2) |
)
)